Work

Abstract 5719: Identification of EIK1004 (IMP1707), a CNS-penetrant, potent, and selective PARP1 inhibitor poised for testing in patients with HRD mutant tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5719

Authors: Melissa Dumble, Ye Edward Tian, Ali Tabatabaei, Brenda Smith, Viola J. Chen, Ning Ma, Xiaozhu Wang, Yuxiao Zhao, Ruiyu Zhou, Yangzhen Jiang, Mu Chen, Sui Xiong Cai

Institution: IMPACT Therapeutics (China)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409636194

Cites:

Cited by:

Related to: 10